Findings from the first-ever prospective trial including a randomized pathway comparing surgery to non-surgical treatment of malignant bowel obstruction (MBO) provide evidence to inform clinical decision-making in managing this frequent complication in patients with advanced cancer.
Dawn L. HershmanPrimo N. Lara, Jr.Primo N. Lara, Jr. and Dawn L. Hershman were elected group co-chairs-elect by the SWOG Cancer Research Network board of governors. The two will serve in that capacity until the term of the current group chair, Charles D. Blanke, ends in spring 2025. They will then begin a six-year term as SWOG’s first group co-chairs.
